Coenzyme Q10 does not improve Parkinson’s disease symptoms
Contact: Alexander Storch
Alexander.Storch@neuro.med.tu-dresden.de
JAMA and Archives Journals
Small doses of the antioxidant coenzyme Q10 appear to increase blood levels of this naturally occurring compound in patients with Parkinson’s disease, but does not improve Parkinson’s disease symptoms, according to an article posted online today that will appear in the July 2007 print issue of Archives of Neurology, one of the JAMA/Archives journals.
Parkinson’s disease is a neurodegenerative disorder characterized by tremors and difficulty with walking or other movements. The biological mechanisms underlying the condition are not fully understood, but researchers suspect a malfunction of the mitochondria, parts of the cells that help convert food to energy, according to background information in the article. Coenzyme (CoQ10), an antioxidant sold as a dietary supplement, is also involved in mitochondrial processes. “Because of these functions, CoQ10 has attracted attention concerning neuroprotective actions in neurodegenerative disorders linked to mitochondrial defects or oxidative [oxygen-related] stress, such as Huntington’s disease and Parkinson’s disease,” the authors write. Previous studies indicate that high doses of CoQ10 (1,200 milligrams) may slow the deterioration associated with Parkinson’s disease.
Alexander Storch, M.D., of the Technical University of Dresden, Germany, and colleagues conducted a randomized clinical trial of a 300-milligram dose of CoQ10 in 131 patients with Parkinson’s disease who did not have changes in motor functions and were on stable treatment for their condition. Those assigned to the treatment group took 100 milligrams of CoQ10 three times daily for three months, followed by a two-month “washout” period. The researchers assessed Parkinson’s disease symptoms before treatment began, each month during treatment and again after the washout period. Blood tests were performed at the beginning of the study, after three months of treatment and after the washout period.
A total of 106 patients completed the full three months of the study—55 in the CoQ10 group and 51 in the placebo group. The compound was well tolerated overall, and the percentage of patients who experienced adverse effects—including viral infection, diarrhea and hearing loss—did not differ between the two groups. Blood levels of CoQ10 increased in the treatment group from an average of 0.99 milligrams per liter to an average of 4.46 milligrams per liter after three months.
“Although we demonstrated a significant increase in plasma levels of CoQ10 toward levels observed with high doses of standard CoQ10 formulations in Parkinson’s disease and other disorders, our study failed to show improvement of Parkinson’s disease symptoms and did not meet its primary or secondary end points,” which were changes on scales that measured Parkinson’s disease symptoms and their effects on physical and mental functioning, the authors write. “Our study further demonstrated that 300 milligrams per day of nanoparticular CoQ10 is safe and well tolerated in patients with Parkinson’s disease already taking various antiparkinsonian medications.”
“Since we did not find symptomatic effects of CoQ10 in Parkinson’s disease, our study does not support the hypothesis that restoring the impaired energy metabolism of the diseased dopaminergic neurons leads to symptomatic benefits in Parkinson’s disease,” the authors conclude. “Future studies will need to explore the protective effects of CoQ10 at the highest effective dose (equivalent to about 2,400 milligrams per day of a standard formulation) over a long treatment period and in a large cohort of patients both sufficient to clearly define the protective potential of this compound in Parkinson’s disease.”
###
(Arch Neurol. 2007;64:(doi:10.1001/archneur.64.7.nct60005). Available pre-embargo to the media at http://www.jamamedia.org.)
Editor’s Note: This study was supported by a grant from the Deutsche Parkinson-Vereinigung eV (German Parkinson Association), Neuss, Germany, and MSE Pharmazeutika GmbH, Bad Homburg, Germany. The co-enzyme Q10 and matching placebo were formulated and packaged without charge by MSE Pharmazeutika. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Global Health Vision
No comments yet.
-
Archives
- January 2009 (1)
- December 2007 (2)
- November 2007 (1)
- October 2007 (11)
- September 2007 (17)
- August 2007 (24)
- July 2007 (25)
- June 2007 (21)
- May 2007 (32)
-
Categories
- 25-hydroxyvitamin D
- Acetaminophen and Caffeine
- Acinetobacter calcoaceticus-baumannii complex
- acute lymphoblastic leukemia
- Alberta
- Alzheimers
- American Academy of Neurology
- American Association for Cancer Research
- American Chemical Society
- American College of Cardiology
- American Heart Association
- American Journal of Clinical Nutrition
- American Journal of Public Health
- American Legacy Foundation
- Ancestral Heritage
- Antibodies
- Archives of Neurology
- Arthritis
- Arthritis & Rheumatism
- ASD
- Autism
- Autism Spectrum Disorders
- Autoimmune Diseases
- B. Rappaport Faculty of Medicine at Technion in Haifa
- Baltimore
- Barcelona
- Bethesda
- Biological Sciences
- Blackwell Publishing Ltd.
- Bone Demineralisation
- Bone Diseases
- Boston
- British Medical Journal
- Brooke Army Medical Center
- Buck Institute
- Calabria Regional Health Department
- Calgary
- Canada
- Canadian Institutes of Health Research
- Cancer
- Cancer Biology
- Cancer Biology and Therapy
- Cancer Information In Spanish
- Cardiovascular Disease
- Catalan Institute of Oncology in Spain
- Chemotherapy
- Childhood Lukemia
- Childhood Nutrition
- Children's Hospital of Philadelphia
- Children’s Cancer Institute Australia
- Children’s Hospital
- Children’s Hospital of Philadelphia
- Childrens Hospital Los Angeles
- Chile
- Chromosome 17
- Chromosome 8
- Chronic
- Chronic Multisymptom Illnesses
- Chronic Stress
- Chronic Stress and Obesity
- CHS National Cancer Control Center and Technion
- CHS National Israeli Cancer Control Center
- Clinical Applications
- Clinical Trials
- Cocaine
- College of Medicine in Houston
- Complex Chronic Conditions
- COPD
- Cornell University
- Cytochrome b5
- Cytochrome P450
- Dementia
- Depression
- Diabetes
- DNA
- Drug Abuse
- Drug-Resistant
- Duke University Medical Center
- Electronic Health Records
- Emergency Preparedness
- Emergency Room
- Emory Genetics Laboratory
- Emory University
- End Of Life Care
- Enzymes
- Epidemiology
- Epilepsy
- European Cancer Conference
- European Journal of Cancer Care
- European League Against Rheumatism
- European Science Foundation
- FDA Warnings
- FEMA
- Fibromyalgia
- Fibromyalgia News
- FMS Global News
- Folic Acid
- Fort Sam Houston
- Fox Chase Cancer Center
- France
- Fred Hutchinson Cancer Research Center
- Garvan Institute of Medical Research
- General Psychiatry
- Genes
- Genetic
- Genetic Link
- Genetic Marker C allele of rs10505477
- Genetics
- Genome
- Genomic
- Germany
- Global
- Global Health Vision
- Global News
- Health
- Health Canada
- Health Information Technology
- Heart Disease
- Hebrew University of Jerusalem
- Hemorrhagic Stroke
- Historical Medicine
- HIV
- Hospital Epidemiology
- Hospital Trauma
- Howard Hughes Medical Institute
- Human Genome
- Hunger
- Huntington's disease
- hypertension
- Imperial College London
- Interactive Autism Network
- Inuit children
- Iraq
- Irvine
- Irving Weinstein Foundation
- Italy
- JAMA
- JAMA/Archives journals
- Japan
- Japanese Society for the Promotion of Science
- Johns Hopkins University
- Joint Health Research Program
- journal BBA Biomembranes
- journal Cell
- journal Nature Genetics
- Journal of Clinical Investigation
- Journal of Experimental Social Psychology
- Journal of the American College of Surgeons
- Journal of Theoretical Biology
- Juvenile Diabetes
- Karolinska Institute in Stockholm
- Kennedy Krieger Institute
- Kyowakai Hospital
- Lamezia Terme
- Leukemia
- LKB1
- London
- London UK Feed
- Lung Cancer
- Lupus
- Malaria
- Massachusetts General Hospital
- Mayo Clinic
- McMaster University
- MD
- Medical History
- Medical Insurance
- Medical Journals
- Mitochondrial Diseases
- Molecular Biology
- Molecular Epidemiology
- MS
- Multiple Sclerosis
- Muscular Dystrophy
- Music Video Of The Day
- Music Video Pick Of The Day
- Nanobiotechnology
- National Cancer Institute
- National Institute on Aging
- National Institutes of Health
- Nature
- Nature Genetics
- Neurodegenerative Diseases
- Neurology
- Neuropeptide Y
- New England Journal of Medicine
- New York University
- Newfoundland
- News
- News Australia
- News Canada
- News France
- News Germany
- News Israel
- News Italy
- News Jerusalem
- News Switzerland
- News UK
- News US
- News USA
- NIH
- non-Hodgkin's lymphoma
- Norepinephrine
- Northwestern University
- Nova Scotia
- Nunavut
- Nutritional Anthropology
- Oak Ridge National Laboratory
- Obesity
- Occupational Health
- omega-3 fatty acids
- Oncology
- Orthopaedic Research Society
- Osaka
- Osteoarthritis
- Ottawa
- Ottawa City Feed
- Oxford University
- Pain
- Pain Management
- Palliative Care
- Parkinson Society of Canada
- Parkinson's
- Pediatric Palliative Care
- Pennsylvania
- Peutz-Jeghers syndrome
- Pharmacology and Neuroscience
- Pick's Disease
- Pre/Post Natal Care
- Preventive Medicine
- Prince Edward Island
- Progranulin
- Protein Growth Factor
- Proteins
- Proteome
- PTSD
- Public Health
- Quebec
- Research
- Research Australia
- Rheumatoid Arthritis
- Rickets
- RSS
- RSS Feed
- Rush Alzheimer’s Disease Center
- Science
- Seattle Washington
- SLE
- Slovakia
- Spain
- Spanish
- Spina Bifida
- Spinal Cord Injuries
- St. Elmos Fire
- St. Jude Children's Research Hospital
- Statin Drugs
- Stem Cells
- Stroke
- Sydney Children’s Hospital
- Systemic Lupus Erythematosus
- TB
- Temple University
- Tendons
- The American Academy of Neurology
- the Israel Institute of Technology
- Toronto
- Toronto City Feed
- trauma-associated and hospital-acquired infection
- Tuberculosis
- Type 1 Diabetes
- Type 2 Diabetes
- UCLA
- UCSD
- UK
- Uncategorized
- Unemployment
- Université Laval
- University College London
- University Hospital in Geneva
- University New South Wales
- University of Bern
- University of Calgary
- University of California
- University of Chicago
- University of Chicago Press Journals
- University of Florida
- University of Granada
- University of Manchester
- University of Michigan
- University of Missouri
- University of North Carolina
- University of North Texas
- University of Nottingham
- University of Oregon
- University of Pennsylvania School of Medicine
- University of Pittsburgh
- University of Rochester
- University of Toronto
- US
- US Army soldiers in Iraq
- US Military Hospitals
- USC
- UT Southwestern Medical Center
- Virginia
- Viruses
- Vitamin D
- W. Garfield Weston Fellows
- Wake Forest University Baptist Medical Center
- WASHINGTON
- Washington DC
- Washington DC City Feed
- Washington University
- Weather Anomolies
- Weill Medical College
- Wellcome Trust
- World Health Organisation
- World News
- Yale University
-
RSS
Entries RSS
Comments RSS
Leave a comment